cervical cancer vaccine: Home-made vaccine for cervical cancer may be rolled out this year

India is likely to introduce a human papillomavirus (HPV) vaccine into the country’s immunization program this year. India’s highest immunization body, the National Technical Advisory Group on Immunization (NTAGI), will make the final decision on the HPV vaccine at a meeting to be held on June 29.

Serum Institute of India (SII) will launch the country’s first native HPV vaccine, experts told ET. “NTAGI is actively considering the rollout of the HPV vaccine in the vaccination program. The safety and efficacy data will be presented to NTAGI and the drug controller at the end of this month,” the person added. NTAGI’s technical subcommittee had previously recommended the introduction of the vaccine. “NTAGI will review the data and make the final decision,” the person added.

The cabinet proposes to have girls aged 9-14 years vaccinated against cervical cancer. Currently, the vaccine is only available in private hospitals and costs up to $4,000 per dose. While the trials of the human papilloma vaccine (HPV) vaccine used for cervical cancer have hit the wall before.

Leave a Comment

Your email address will not be published.